Cannula Market Size, Share, Industry Overview, Latest Insights and Forecast 2026-2034

According to IMARC Group, the global Cannula Market Size was valued at USD 177.6 Million in 2025 and is projected to reach USD 285.5 Million by 2034, growing at a CAGR of 5.26% during 2026-2034. This sustained Cannula Market Growth is powered by the rising global burden of chronic diseases, expanding demand for minimally invasive surgical procedures, technological innovations in cannula design, and increasing investment in healthcare infrastructure across emerging economies.

Cannula Industry Overview:

A cannula is a thin tube inserted into the body to deliver or extract fluids, administer medications, provide oxygen, or facilitate access during surgical procedures. Available in a wide range of sizes, materials, and configurations, cannulas are fundamental tools across nearly every medical specialty - from emergency medicine and intensive care to cardiology, aesthetics, and orthopaedics.

The cannula industry spans a diverse product ecosystem:

• Cardiac Cannulas - used in CABG, valve replacements, and heart bypass surgeries
• Nasal Cannulas - essential for oxygen therapy in respiratory disorders
• Vascular Cannulas - enabling IV access, blood transfusions, and haemodialysis
• Dermatology Cannulas - deployed in filler injections, liposuction, and fat grafting
• Arthroscopy Cannulas - providing portal access in minimally invasive joint procedures

End users range from acute-care hospitals and ambulatory surgery centres (ASCs) to home healthcare providers and long-term care institutions, making cannulas one of the most pervasively used disposable medical devices in global healthcare.

Global Cannula Market Size & Key Statistics:

Below are the key Cannula Market statistics drawn from IMARC Group's comprehensive market analysis:

Base Year - 2025
Historical Period - 2020-2025
Forecast Period - 2026-2034
Cannula Market Size in 2025 - USD 177.6 Million
Market Forecast in 2034 - USD 285.5 Million
Market Growth Rate (2026-2034) - 5.26% CAGR
Largest Region - North America
Leading Product Segment - Cardiac Cannulas
Leading Type Segment - Straight Cannulas
Leading Size Segmentv - 18G
Leading Material Segment - Plastic (PVC) Cannulas
Leading End-User Segment - Hospitals

Request for a Sample Report for Detailed Cannula Market Share Evaluation: https://www.imarcgroup.com/cannula-market/requestsample

Key Market Drivers & Cannula Market Trends in 2026:

Several powerful forces are shaping the Cannula Market Trends and fuelling steady growth expectations across global medical device markets:

1. Growing Need for Minimally Invasive Procedures:

The cannula market is growing at a very fast rate due to the increasing number of medical professionals incorporating minimally invasive procedures. These procedures reduce patient recovery time and minimise the risk of complications compared to conventional surgeries. As patients seek solutions offering quicker recovery and fewer side effects, medical centres are progressively using cannulas across oncology, cardiology, and cosmetic surgeries. The global minimally invasive surgery market is projected to attain USD 94.9 Billion by 2033, creating a strong long-term demand tailwind for cannulas.

2. Rising Prevalence of Chronic Diseases:

The increased prevalence of chronic diseases - including cardiovascular disorders, diabetes, cancer, and respiratory conditions - is a primary driver of Cannula Market Growth. Patients with chronic diseases typically require ongoing treatments such as chemotherapy, dialysis, or insulin administration, where cannulas provide fast, reliable vascular access. The WHO projects that the global population aged 60 and above will reach 1.4 billion by 2030 and 2.1 billion by 2050, substantially expanding the chronic-care patient base and associated demand for cannula-based interventions.

3. Technological Advancements in Cannula Design:

Technology advancements are constantly evolving and enhancing cannula designs, fuelling Cannula Market Growth substantially. New materials including flexible, biocompatible polymers are reducing patient discomfort and minimising complications like infection or blood clots. Innovations such as self-sealing mechanisms, enhanced ergonomic profiles, and micro-cannula formats are improving clinical precision. Auxein's introduction of the Auxilock Silicon Cannula and Auxilock Rigid Threaded Cannula at MEDICA 2024 exemplifies how product innovation continues to reshape what is clinically possible with these devices.

4. Growing Demand for Cosmetic Procedures:

The growing popularity of cosmetic and aesthetic procedures is a key Cannula Market Trend driving specialised demand. Techniques such as fat grafting, liposuction, and non-surgical facial treatments - particularly dermal filler injections - now favour cannulas over conventional needles due to lower bruising risk and greater precision. As medical aesthetics continues to expand globally and patients seek minimally invasive procedures with natural-looking outcomes and minimal downtime, dermatology cannulas represent one of the fastest-growing product sub-segments.

5. Increasing Awareness About Infection Control and Safety:

Growing awareness regarding infection control and patient safety norms across healthcare environments is propelling demand for single-use, pre-sterile cannulas. As hospitals and clinics increasingly prioritise preventing healthcare-associated infections (HAIs), particularly in ICUs and surgical theatres, disposable cannulas are becoming the standard of care. This infection-control imperative is directly boosting both volume and value in the cannula market, especially for PVC and silicone cannula variants.

6. Government Initiatives and Healthcare Investments:

Government policies and rising healthcare expenditure are major drivers supporting the Cannula Market Size expansion globally. Most governments are prioritising healthcare infrastructure development and improving access to quality care, especially in emerging economies. As healthcare budgets increase, governments are allocating more funds for medical device procurement, including cannulas. Regulatory agencies are reinforcing quality and safety standards, further building trust and driving adoption. In 2023, InspiraTM Technologies received a USPTO patent for its novel convertible dual lumen cannula, illustrating active innovation and regulatory engagement in the sector.

7. Expanding Medical Tourism and Home Healthcare:

The expanding global medical tourism sector - particularly across Asia-Pacific, Latin America, and the Middle East - is increasing the volume of surgical procedures performed, directly boosting cannula consumption. Simultaneously, the growing shift towards home healthcare services and long-term care institutions is expanding the use of nasal cannulas for oxygen therapy and vascular cannulas for chronic disease management outside hospital settings - a key emerging Cannula Market Trend.

Key Market Segmentation:

By Product:

Cardiac Cannulas - Largest Segment: Cardiac cannulas dominate the product segment due to their essential role in open-heart surgeries, CABG, and valve replacements. These specialised devices enable accurate administration of medications, fluids, and anaesthesia, and facilitate efficient drainage and irrigation during complex cardiac procedures. The rising global incidence of cardiovascular diseases is sustaining and expanding demand for this product category.

Nasal Cannulas: Widely used in oxygen therapy for patients with respiratory disorders, nasal cannulas represent a significant and stable segment supported by rising rates of COPD, asthma, and other pulmonary conditions globally.
Vascular, Dermatology & Arthroscopy Cannulas: These segments are growing in line with expanding procedural volumes in vascular access, aesthetic medicine, and minimally invasive orthopaedic surgery respectively.

By Type:

Straight Cannulas - Largest Segment: Straight cannulas command the largest type share due to their broad clinical applicability across IV therapy, blood transfusions, diagnostic procedures, and emergency care. Their straightforward form, ease of insertion, affordability, and simplicity make them the default choice for healthcare facilities worldwide.

Winged Cannulas & Wing with Port Cannulas: These types offer enhanced anchoring and medication port access, increasingly preferred in settings requiring extended cannulation duration.

Neonatal Cannulas: Specialised for paediatric and neonatal care, this segment is supported by investments in neonatal ICU infrastructure globally.

By Size:

18G - Largest Segment: The 18G cannula is the most widely used size, balancing fluid flow rate and patient comfort across IV therapy, blood transfusions, and emergency medicine. Its versatility in administering medications rapidly in life-threatening circumstances makes it the standard size across clinical settings globally.

Other available sizes range from 14G (large-bore, high-flow applications) to 26G (paediatric and delicate vascular access), with size selection driven by clinical indication and patient characteristics.

By Material:

Plastic (PVC) Cannulas - Largest Segment: PVC cannulas dominate the material segment due to their adaptability, cost-effectiveness, and suitability across a wide range of procedures. Their ability to maintain sterile conditions, efficient blood flow characteristics in venepuncture, and lightweight-yet-durable design make them the standard choice for both short-term treatments and long-term chronic care settings directly contributing to the Cannula Market Size.

Silicone Cannulas: Preferred in applications requiring enhanced biocompatibility and flexibility, particularly in cosmetic and specialised surgical procedures.

Metal Cannulas (Stainless Steel): Used where rigidity and precision are paramount, including certain arthroscopic and surgical access applications.

By Application:

Cardiovascular Surgery - Largest Application: The highest application segment, reflecting the global prevalence of heart disease and the clinical essentiality of cardiac cannulas in CABG and valve replacement procedures.

Oxygen Therapy: Nasal cannulas for short-term and long-term oxygen supplementation represent a consistently high-demand segment, supported by rising respiratory disease burdens worldwide.

Cosmetic/Plastic Surgery: The fastest-growing application sub-segment, reflecting the global expansion of non-surgical aesthetic procedures and demand for micro-cannulas in dermal filler delivery and fat grafting.

General Surgery, Orthopaedic Surgery & Others: Cannulas are routinely used across all surgical specialties for IV access, fluid delivery, and portal creation, ensuring broad and stable demand.

By End-User:

Hospitals - Largest End-User: Hospitals account for the dominant end-user share due to high patient volumes and the comprehensive range of medical procedures performed across ICUs, emergency departments, surgical theatres, and general wards. The sheer volume of IV therapies, transfusions, and surgeries in hospitals sustains consistent, large-scale cannula consumption.
Ambulatory Surgery Centers (ASCs): ASCs are a rapidly growing end-user segment, driven by the global shift towards outpatient care, where cannulas are used for IV access and procedure facilitation in day-surgery environments.
Others (Home Healthcare, Long-Term Care Institutions): The shift towards home-based management of chronic diseases and respiratory conditions is driving cannula demand outside traditional institutional settings.

Regional Cannula Market Analysis

North America - Largest: United States & Canada; sophisticated healthcare system, high prevalence of chronic illnesses, extensive R&D investment, strong reimbursement policies, high patient safety standards, active patent activity.

Europe: Germany, France, UK, Italy, Spain, Russia; mature healthcare infrastructure, EU MDR regulatory framework driving quality standards, growing demand for minimally invasive procedures.

Asia Pacific: China, Japan, India, South Korea, Australia, Indonesia; fast-expanding healthcare sector, rising surgical procedure volumes, growing medical tourism, increasing government healthcare investment.

Latin America: Brazil, Mexico; Brazil is the largest LatAm healthcare market, growing demand for medical devices as healthcare infrastructure expands and medical tourism increases.

Middle East & Africa: UAE, Saudi Arabia, South Africa; healthcare modernisation programmes (Saudi Vision 2030), rising chronic disease burden, growing medical tourism driving surgical volume and cannula demand

North America leads the global Cannula Market Share, driven by its sophisticated healthcare system, high prevalence of cardiovascular and chronic diseases, extensive R&D investment, and strong regulatory frameworks. The United States and Canada prioritise patient safety, efficiency, and quality of service across medical specialties - including cardiology, oncology, and emergency medicine - all of which are high cannula-utilisation environments. Favourable reimbursement policies and strong healthcare legislation further support adoption of new cannula technologies in clinical practice.

Asia-Pacific represents the fastest-growing regional opportunity, with expanding healthcare infrastructure, rising surgical procedure volumes, and growing medical tourism driving consistent Cannula Market Growth across China, Japan, India, and South Korea. Government investments under initiatives such as India's Ayushman Bharat and Japan's Precision Medicine Initiative are accelerating healthcare capacity and device adoption.

Connect for Detailed Cannula Market Share and Segmentation Analysis - Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=2252&flag=C

Leading Players in the Cannula Industry:

The global cannula market features a competitive mix of diversified medical device corporations and specialist manufacturers. Key companies covered in the IMARC Group report include:

• Boston Scientific Corporation
• CONMED Corporation
• Edwards Lifesciences
• Medtronic Plc
• Smith & Nephew PLC
• Smiths Medical Inc.
• LivaNova Plc
• Teleflex Incorporated
• Terumo Corporation

The report includes competitive analysis covering market structure, player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Major firms are actively investing in R&D, strategic alliances, and geographical expansion into emerging markets to strengthen their Cannula Market Share globally.

Latest Industry Developments:

May 2025 - Vapotherm, Inc.

Vapotherm announced the publication of a new clinical study in Critical Care Explorations demonstrating that the ProSoft® UnicornTM Cannula - a single-prong high velocity therapy device - provides comparable relief from dyspnea at significantly lower gas flow rates compared to conventional dual-prong cannulas. This advance signals an important Cannula Market Trend towards optimised, patient-friendly high-flow nasal cannula designs.

April 2025 - Northern Meditec:

Northern Meditec's High-Flow Nasal Cannula Respiratory Humidifiers (HF3) received EU Medical Device Regulation (MDR) certification from SGS FIMKO OY Notified Body 0598, meeting the rigorous standards of the European market under EU MDR (EU) 2017/745 Annex IX. This approval opens the door to expanded pan-European market access and supports Cannula Market Growth in the European respiratory care segment.

February 2025 - ClearPoint Neuro, Inc.

ClearPoint Neuro obtained EU MDR approval for the SmartFlow Neuro Cannula - well ahead of the 2027 Class III device deadline - with the certification also extending the product's EU shelf life from 24 to 48 months. The SmartFlow Cannula had previously received FDA De Novo marketing authorisation in November 2024, approved for intraputaminal delivery of PTC Therapeutics' gene therapy KEBILIDITM for AADC deficiency - a landmark milestone for cannula use in precision gene therapy delivery.

January 2025 - Terumo Corporation:

Terumo Corporation revealed the global introduction of the Terumo Injection Filter Needle, the initial phase of the INFINOTM Development Program. The device incorporates a built-in 5-micrometer mesh filter to block particles from injection, featuring an ultra-thin-walled (ETW) cannula delivering over four times the flow rate compared to standard-wall alternatives - advancing both safety and performance standards in the injectable cannula segment.

February 2025 - Airglove Medical:

Airglove Medical secured £500,000 in equity funding from Pulse Angels and Scottish Enterprise to support commercialisation of its patented Airglove device - designed to assist healthcare professionals in successfully cannulating patients on the first attempt, directly addressing the clinical challenge of difficult venous access.

About Us:

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Technology, Construction, Healthcare, Energy, Food & Beverages, and more.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1-201971-6302

This release was published on openPR.